BioNTech (Germany) Market Value
| 22UA Stock | EUR 113.80 1.30 1.16% |
| Symbol | BioNTech |
BioNTech 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to BioNTech's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of BioNTech.
| 10/28/2024 |
| 11/27/2024 |
If you would invest 0.00 in BioNTech on October 28, 2024 and sell it all today you would earn a total of 0.00 from holding BioNTech SE or generate 0.0% return on investment in BioNTech over 30 days. BioNTech is related to or competes with Superior Plus, NMI Holdings, Origin Agritech, SIVERS SEMICONDUCTORS, Talanx AG, NorAm Drilling, and Identiv. BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseas... More
BioNTech Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure BioNTech's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess BioNTech SE upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.18 | |||
| Information Ratio | 0.1182 | |||
| Maximum Drawdown | 26.8 | |||
| Value At Risk | (6.10) | |||
| Potential Upside | 6.63 |
BioNTech Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for BioNTech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as BioNTech's standard deviation. In reality, there are many statistical measures that can use BioNTech historical prices to predict the future BioNTech's volatility.| Risk Adjusted Performance | 0.1231 | |||
| Jensen Alpha | 0.4883 | |||
| Total Risk Alpha | (0.03) | |||
| Sortino Ratio | 0.148 | |||
| Treynor Ratio | 0.6909 |
BioNTech SE Backtested Returns
BioNTech appears to be very steady, given 3 months investment horizon. BioNTech SE secures Sharpe Ratio (or Efficiency) of 0.16, which signifies that the company had a 0.16% return per unit of risk over the last 3 months. By analyzing BioNTech's technical indicators, you can evaluate if the expected return of 0.64% is justified by implied risk. Please makes use of BioNTech's Downside Deviation of 3.18, mean deviation of 2.61, and Risk Adjusted Performance of 0.1231 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, BioNTech holds a performance score of 12. The firm shows a Beta (market volatility) of 0.85, which signifies possible diversification benefits within a given portfolio. BioNTech returns are very sensitive to returns on the market. As the market goes up or down, BioNTech is expected to follow. Please check BioNTech's downside deviation, standard deviation, total risk alpha, as well as the relationship between the coefficient of variation and jensen alpha , to make a quick decision on whether BioNTech's price patterns will revert.
Auto-correlation | 0.07 |
Virtually no predictability
BioNTech SE has virtually no predictability. Overlapping area represents the amount of predictability between BioNTech time series from 28th of October 2024 to 12th of November 2024 and 12th of November 2024 to 27th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of BioNTech SE price movement. The serial correlation of 0.07 indicates that barely 7.0% of current BioNTech price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.07 | |
| Spearman Rank Test | -0.11 | |
| Residual Average | 0.0 | |
| Price Variance | 37.56 |
BioNTech SE lagged returns against current returns
Autocorrelation, which is BioNTech stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting BioNTech's stock expected returns. We can calculate the autocorrelation of BioNTech returns to help us make a trade decision. For example, suppose you find that BioNTech has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
BioNTech regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If BioNTech stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if BioNTech stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in BioNTech stock over time.
Current vs Lagged Prices |
| Timeline |
BioNTech Lagged Returns
When evaluating BioNTech's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of BioNTech stock have on its future price. BioNTech autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, BioNTech autocorrelation shows the relationship between BioNTech stock current value and its past values and can show if there is a momentum factor associated with investing in BioNTech SE.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in BioNTech Stock
When determining whether BioNTech SE offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of BioNTech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biontech Se Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biontech Se Stock:Check out BioNTech Correlation, BioNTech Volatility and BioNTech Alpha and Beta module to complement your research on BioNTech. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
BioNTech technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.